Trademark Overview
On Wednesday, March 6, 2024, a trademark application was filed for INFLAMOSTAT with the United States Patent and Trademark Office. The USPTO has given the INFLAMOSTAT trademark a serial number of 98436739. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, September 21, 2024. This trademark is owned by 3Helix Inc.. The INFLAMOSTAT trademark is filed in the Cosmetics & Cleaning Products and Pharmaceutical Products categories with the following description:
Synthetic and collagen peptides for use in the fields of medical diagnostics and biotechnology, namely, for the treatment of various conditions and diseases, including T-Cell mediated diseases; pharmaceutical preparations for use in the fields of medical diagnostics and biotechnology, namely, topical drugs for the treatment of various conditions and diseases, including T-Cell mediated diseases; synthetic and collagen peptides for pharmaceutical purposes for the treatment of various conditions and diseases, including T-Cell mediated diseases; synthetic and collagen peptides sold as an ingredient in pharmaceutical preparations for the treatment of various conditions and diseases, including T-Cell mediated diseases; chemical preparations for medical purposes, namely, for coating medical devices, wound dressings, and delivering medicine for the treatment of various conditions and diseases; drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceut...
Cosmetics; synthetic and collagen peptides sold as an ingredient in cosmetics
